Tetsuro Araki, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thymus Neoplasms | 5 | 2022 | 277 | 1.970 |
Why?
|
Thymus Hyperplasia | 4 | 2021 | 32 | 1.780 |
Why?
|
Lung Diseases, Interstitial | 14 | 2022 | 945 | 1.180 |
Why?
|
Pleura | 2 | 2017 | 248 | 1.020 |
Why?
|
Asbestos | 2 | 2017 | 251 | 1.010 |
Why?
|
Pulmonary Emphysema | 7 | 2024 | 690 | 0.870 |
Why?
|
Tomography, X-Ray Computed | 27 | 2024 | 20765 | 0.770 |
Why?
|
Lung | 18 | 2022 | 10089 | 0.760 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2022 | 489 | 0.680 |
Why?
|
Thymus Gland | 2 | 2015 | 1266 | 0.660 |
Why?
|
Pleural Diseases | 2 | 2017 | 138 | 0.660 |
Why?
|
Iodine | 2 | 2021 | 286 | 0.650 |
Why?
|
Pseudolymphoma | 2 | 2015 | 30 | 0.580 |
Why?
|
Diaphragm | 4 | 2019 | 359 | 0.520 |
Why?
|
Respiratory Function Tests | 8 | 2019 | 1696 | 0.480 |
Why?
|
Mediastinal Cyst | 1 | 2014 | 30 | 0.460 |
Why?
|
Idiopathic Pulmonary Fibrosis | 4 | 2019 | 520 | 0.430 |
Why?
|
Lymphoma | 1 | 2021 | 1907 | 0.390 |
Why?
|
Neuroblastoma | 1 | 2020 | 1266 | 0.380 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 658 | 0.370 |
Why?
|
Radiography, Thoracic | 4 | 2019 | 1320 | 0.360 |
Why?
|
Mucin-5B | 5 | 2019 | 148 | 0.350 |
Why?
|
Cysts | 1 | 2015 | 685 | 0.350 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2925 | 0.340 |
Why?
|
Respiration | 5 | 2019 | 1667 | 0.330 |
Why?
|
Carcinoma | 1 | 2020 | 2341 | 0.310 |
Why?
|
Lung Diseases | 2 | 2015 | 1925 | 0.300 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 7 | 2022 | 3243 | 0.300 |
Why?
|
Pulmonary Fibrosis | 2 | 2024 | 506 | 0.280 |
Why?
|
Smoking | 6 | 2019 | 9111 | 0.260 |
Why?
|
Environmental Exposure | 2 | 2018 | 4528 | 0.250 |
Why?
|
Forced Expiratory Volume | 5 | 2019 | 1820 | 0.230 |
Why?
|
Positron-Emission Tomography | 3 | 2015 | 6670 | 0.210 |
Why?
|
Pulmonary Veins | 1 | 2019 | 754 | 0.210 |
Why?
|
Tobacco Smoke Pollution | 1 | 2019 | 827 | 0.210 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4907 | 0.210 |
Why?
|
Aged | 28 | 2021 | 171562 | 0.190 |
Why?
|
Disease Progression | 3 | 2019 | 13646 | 0.190 |
Why?
|
Polymorphism, Genetic | 3 | 2017 | 4250 | 0.190 |
Why?
|
Age Factors | 6 | 2021 | 18471 | 0.180 |
Why?
|
Pulmonary Artery | 1 | 2019 | 1945 | 0.170 |
Why?
|
Middle Aged | 28 | 2021 | 223491 | 0.170 |
Why?
|
Female | 39 | 2021 | 397089 | 0.170 |
Why?
|
Iceland | 4 | 2020 | 183 | 0.160 |
Why?
|
Male | 37 | 2021 | 364902 | 0.160 |
Why?
|
Lung Neoplasms | 6 | 2020 | 13576 | 0.160 |
Why?
|
Vital Capacity | 4 | 2019 | 984 | 0.160 |
Why?
|
Bronchiectasis | 1 | 2020 | 139 | 0.160 |
Why?
|
Spirometry | 4 | 2019 | 928 | 0.150 |
Why?
|
Posture | 3 | 2017 | 956 | 0.150 |
Why?
|
Tidal Volume | 2 | 2019 | 515 | 0.150 |
Why?
|
Asbestosis | 1 | 2017 | 81 | 0.150 |
Why?
|
Prevalence | 5 | 2017 | 15872 | 0.140 |
Why?
|
Humans | 45 | 2024 | 768393 | 0.140 |
Why?
|
Movement | 3 | 2019 | 1490 | 0.130 |
Why?
|
Longitudinal Studies | 7 | 2021 | 14784 | 0.130 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2015 | 60 | 0.120 |
Why?
|
Galectin 3 | 1 | 2016 | 240 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 281 | 0.120 |
Why?
|
Xenon Isotopes | 1 | 2014 | 67 | 0.110 |
Why?
|
Helium | 1 | 2014 | 119 | 0.110 |
Why?
|
Thoracic Neoplasms | 1 | 2016 | 269 | 0.110 |
Why?
|
Chemokine CXCL10 | 1 | 2015 | 312 | 0.110 |
Why?
|
Adult | 16 | 2021 | 223640 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 6 | 2020 | 36849 | 0.110 |
Why?
|
Aged, 80 and over | 12 | 2020 | 59686 | 0.110 |
Why?
|
Proportional Hazards Models | 5 | 2020 | 12558 | 0.110 |
Why?
|
Vehicle Emissions | 1 | 2018 | 656 | 0.110 |
Why?
|
Thymoma | 1 | 2014 | 191 | 0.100 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 589 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2018 | 3411 | 0.100 |
Why?
|
Promoter Regions, Genetic | 3 | 2019 | 5801 | 0.100 |
Why?
|
Radiography | 3 | 2019 | 6993 | 0.100 |
Why?
|
Linear Models | 4 | 2019 | 5878 | 0.100 |
Why?
|
Carbon Monoxide | 1 | 2015 | 552 | 0.100 |
Why?
|
Uterine Diseases | 1 | 2012 | 108 | 0.090 |
Why?
|
Pleural Neoplasms | 1 | 2016 | 612 | 0.090 |
Why?
|
Cohort Studies | 10 | 2022 | 41795 | 0.090 |
Why?
|
Mannose | 1 | 2010 | 120 | 0.090 |
Why?
|
Aging | 2 | 2021 | 8764 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 13020 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2018 | 9433 | 0.080 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 5422 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20224 | 0.070 |
Why?
|
Observer Variation | 1 | 2014 | 2623 | 0.070 |
Why?
|
Liver Neoplasms | 2 | 2016 | 4365 | 0.070 |
Why?
|
Exhalation | 2 | 2019 | 185 | 0.070 |
Why?
|
Retrospective Studies | 7 | 2019 | 81801 | 0.070 |
Why?
|
Logistic Models | 5 | 2019 | 13323 | 0.070 |
Why?
|
Serine | 1 | 2010 | 831 | 0.070 |
Why?
|
Liposomes | 1 | 2010 | 792 | 0.070 |
Why?
|
Particulate Matter | 1 | 2018 | 2609 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3766 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12092 | 0.060 |
Why?
|
Radiographic Image Enhancement | 1 | 2010 | 877 | 0.060 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2587 | 0.060 |
Why?
|
Cause of Death | 1 | 2016 | 3728 | 0.060 |
Why?
|
Forecasting | 1 | 2014 | 2948 | 0.060 |
Why?
|
Health Status | 1 | 2018 | 4094 | 0.060 |
Why?
|
Fatty Liver | 1 | 2011 | 807 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2019 | 9063 | 0.060 |
Why?
|
Sex Characteristics | 1 | 2015 | 2660 | 0.060 |
Why?
|
Total Lung Capacity | 2 | 2015 | 149 | 0.060 |
Why?
|
Air Pollution | 1 | 2018 | 2363 | 0.060 |
Why?
|
Organ Size | 1 | 2019 | 2268 | 0.060 |
Why?
|
Odds Ratio | 3 | 2021 | 9682 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3541 | 0.050 |
Why?
|
Survival Rate | 3 | 2021 | 12870 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10654 | 0.050 |
Why?
|
Body Mass Index | 2 | 2015 | 13052 | 0.040 |
Why?
|
TATA Box Binding Protein-Like Proteins | 1 | 2019 | 9 | 0.040 |
Why?
|
Contrast Media | 2 | 2011 | 5336 | 0.040 |
Why?
|
Risk Factors | 2 | 2018 | 74962 | 0.040 |
Why?
|
beta Karyopherins | 1 | 2019 | 46 | 0.040 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2021 | 199 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 3777 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14737 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18048 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15649 | 0.030 |
Why?
|
Telomere | 1 | 2022 | 943 | 0.030 |
Why?
|
Prospective Studies | 5 | 2019 | 54920 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2862 | 0.030 |
Why?
|
X-Rays | 1 | 2016 | 312 | 0.030 |
Why?
|
Thorax | 1 | 2019 | 559 | 0.030 |
Why?
|
Denmark | 1 | 2018 | 779 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2019 | 22296 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39407 | 0.030 |
Why?
|
Isotopes | 1 | 2014 | 125 | 0.030 |
Why?
|
Young Adult | 3 | 2018 | 60049 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11854 | 0.030 |
Why?
|
Incidental Findings | 1 | 2019 | 698 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26375 | 0.030 |
Why?
|
Motion | 1 | 2016 | 789 | 0.030 |
Why?
|
Japan | 1 | 2016 | 1418 | 0.030 |
Why?
|
Registries | 2 | 2019 | 8379 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2014 | 1169 | 0.020 |
Why?
|
Genotype | 2 | 2017 | 13042 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2630 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15939 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3623 | 0.020 |
Why?
|
Magnetite Nanoparticles | 1 | 2011 | 318 | 0.020 |
Why?
|
Dextrans | 1 | 2011 | 574 | 0.020 |
Why?
|
China | 1 | 2015 | 2395 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2018 | 2433 | 0.020 |
Why?
|
Aortography | 1 | 2010 | 422 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 30022 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1226 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2011 | 823 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3813 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10117 | 0.020 |
Why?
|
Leiomyoma | 1 | 2012 | 644 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3236 | 0.020 |
Why?
|
Regression Analysis | 1 | 2015 | 6350 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6856 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2734 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11254 | 0.010 |
Why?
|
Rabbits | 1 | 2010 | 4781 | 0.010 |
Why?
|
Endometriosis | 1 | 2012 | 875 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2011 | 18362 | 0.010 |
Why?
|
Exercise | 1 | 2018 | 5946 | 0.010 |
Why?
|
Image Enhancement | 1 | 2011 | 2894 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12778 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16028 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8199 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14154 | 0.010 |
Why?
|
Software | 1 | 2012 | 4453 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9198 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6567 | 0.010 |
Why?
|
Rats | 1 | 2011 | 23835 | 0.010 |
Why?
|
Liver | 1 | 2010 | 7574 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 89184 | 0.010 |
Why?
|
Animals | 2 | 2011 | 169337 | 0.000 |
Why?
|
Neoplasms | 1 | 2016 | 22385 | 0.000 |
Why?
|
United States | 1 | 2015 | 73150 | 0.000 |
Why?
|